Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL436 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL7743392 | 1.00 | SLC34A1 (0.46) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL2989706 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL1979287 | 0.94 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL6540946 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL2181871 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL1291546 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL1835681 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL7525209 | 0.94 | LMNA (0.43) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL15066667 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11576413-B2 | Compositions comprising ionized cannabidiol | Natural Extraction Systems, LLC (US) | 2023-02-14 | — | — | US | claimed |
| EP-4066302-A1 | STABLE AQUEOUS COMPOSITIONS COMPRISING QUINONES, AND USE THEREOF IN REDOX FLOW BATTERIES | Technische Universität Graz (AT) | 2022-10-05 | — | — | EP | claimed |
| US-20200315229-A1 | COMPOSITIONS COMPRISING IONIZED CANNABIDIOL | Natural Extraction Systems, LLC | 2020-10-08 | — | — | US | claimed |
| CN-116539892-B | Renal clear cell carcinoma protein marker and auxiliary diagnosis model construction method | 上海交通大学医学院附属新华医院 | 2024-03-26 | — | — | CN | disclosed |
| CN-116539892-A | Renal clear cell carcinoma protein marker and auxiliary diagnosis model construction method | 上海交通大学医学院附属新华医院 | 2023-08-04 | — | — | CN | disclosed |
| WO-2023131254-A1 | PSEUDOURIDINE MODIFIED AT N1 POSITION AND USE THEREOF IN MRNA SYNTHESIS | 上海吉量医药工程有限公司 | 2023-07-13 | — | — | WO | disclosed |
| US-11576413-B2 | Compositions comprising ionized cannabidiol | Natural Extraction Systems, LLC (US) | 2023-02-14 | — | — | US | disclosed |
| EP-4066302-A1 | STABLE AQUEOUS COMPOSITIONS COMPRISING QUINONES, AND USE THEREOF IN REDOX FLOW BATTERIES | Technische Universität Graz (AT) | 2022-10-05 | — | — | EP | disclosed |
| US-20220023773-A1 | COMPOSITIONS COMPRISING 2-[(1R,6R)-6-ISOPROPENYL-3-METHYLCYCLOHEX-2-EN-1-YL]-3-HYDROXY-5-PENTYLPHENOLATE | WAGNER ROBERT C (US) | 2022-01-27 | — | — | US | disclosed |
| US-20200315229-A1 | COMPOSITIONS COMPRISING IONIZED CANNABIDIOL | Natural Extraction Systems, LLC | 2020-10-08 | — | — | US | disclosed |
| US-5489420-A | SELECTIVE NONCATALYTIC REDUCTION IN GAS PHASE AT HIGH TEMPERATURES BY USING AN NH-CONTAINING REDUCING AGENT SUCH AS UREA | NALCO FUEL TECH (US) | 1996-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200315229-A1 | COMPOSITIONS COMPRISING IONIZED CANNABIDIOL | CNR1, CNR2, PLCB3 | SLC34A1 4262/4885LMNA 2464/4885 |
| US-20220023773-A1 | COMPOSITIONS COMPRISING 2-[(1R,6R)-6-ISOPROPENYL-3-METHYLCYCLOHEX-2-EN-1-YL]-3-HYDROXY-5-PENTYLPHENOLATE | HTR6, UGT1A6, MPHOSPH6 | SLC34A1 4109/4885LMNA 2479/4885 |
| US-11576413-B2 | Compositions comprising ionized cannabidiol | CNR1, CNR2, PLCB3 | SLC34A1 4262/4885LMNA 2464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.